tradingkey.logo

Orchestra Biomed Holdings Inc

OBIO
4.410USD
+0.060+1.38%
Close 12/22, 16:00ETQuotes delayed by 15 min
249.01MMarket Cap
LossP/E TTM
You can find the annual or quarterly income statement of Orchestra Biomed Holdings Inc here for insights into the performance and operational efficiency of Orchestra Biomed Holdings Inc.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
Total revenue
-12.77%861.00K
7.46%836.00K
40.00%868.00K
-3.44%253.00K
135.56%987.00K
-14.97%778.00K
-46.74%620.00K
-76.25%262.00K
-63.97%419.00K
128.18%915.00K
34.41%1.16M
144.97%1.10M
-12.75%1.16M
141.00%401.00K
-34.19%866.00K
---2.45M
--1.33M
---978.00K
--1.32M
Revenue
-12.77%861.00K
7.46%836.00K
40.00%868.00K
-3.44%253.00K
135.56%987.00K
-14.97%778.00K
-46.74%620.00K
-76.25%262.00K
-63.97%419.00K
128.18%915.00K
34.41%1.16M
144.97%1.10M
-12.75%1.16M
141.00%401.00K
-34.19%866.00K
---2.45M
--1.33M
---978.00K
--1.32M
Cost of revenue
-27.94%49.00K
4.55%46.00K
29.41%44.00K
23.40%58.00K
65.85%68.00K
-18.52%44.00K
-22.73%34.00K
-11.32%47.00K
-26.79%41.00K
575.00%54.00K
4.76%44.00K
-8.62%53.00K
27.27%56.00K
-87.10%8.00K
20.00%42.00K
--58.00K
--44.00K
--62.00K
--35.00K
Operating expenses
22.19%21.17M
14.32%20.16M
31.55%19.79M
32.86%16.93M
15.97%17.33M
27.15%17.64M
18.36%15.04M
16.58%12.74M
33.06%14.94M
72.63%13.87M
112.03%12.71M
100.42%10.93M
96.33%11.23M
74.45%8.04M
14.45%5.99M
--5.45M
--5.72M
--4.61M
--5.24M
R&D expenses
20.97%14.03M
24.51%13.85M
47.96%13.48M
28.90%10.97M
35.49%11.60M
30.91%11.13M
10.39%9.11M
12.83%8.51M
45.08%8.56M
72.95%8.50M
137.59%8.25M
113.62%7.54M
61.22%5.90M
86.35%4.91M
13.42%3.47M
--3.53M
--3.66M
--2.64M
--3.06M
Depreciation, depletion, and amortization
6.58%81.00K
9.46%81.00K
12.16%83.00K
16.67%84.00K
7.04%76.00K
1.37%74.00K
4.23%74.00K
2.86%72.00K
31.48%71.00K
46.00%73.00K
47.92%71.00K
45.83%70.00K
17.39%54.00K
13.64%50.00K
11.63%48.00K
--48.00K
--46.00K
--44.00K
--43.00K
Operating profit
-24.30%-20.31M
-14.64%-19.33M
-31.19%-18.92M
-33.62%-16.68M
-12.52%-16.34M
-30.13%-16.86M
-24.93%-14.42M
-26.99%-12.48M
-44.27%-14.52M
-69.71%-12.96M
-125.14%-11.54M
-24.29%-9.83M
-129.47%-10.07M
-36.71%-7.63M
-30.78%-5.13M
---7.91M
---4.39M
---5.58M
---3.92M
Net non-operating interest income (expenses)
Special income (expenses)
----
----
100.00%0.00
100.00%0.00
-100.00%0.00
25.81%-23.00K
83.93%-45.00K
-269.57%-1.45M
205.40%293.00K
-193.94%-31.00K
23.29%-280.00K
-529.67%-391.00K
59.48%-278.00K
111.91%33.00K
-162.50%-365.00K
--91.00K
---686.00K
---277.00K
--584.00K
Other non-operating income (expenses)
----
----
100.00%0.00
--0.00
--0.00
--0.00
---11.00K
----
----
----
----
----
----
----
----
----
----
----
----
Income before tax
-35.02%-20.83M
-21.17%-19.36M
-39.31%-18.75M
-26.03%-16.16M
-15.85%-15.43M
-32.66%-15.98M
-23.06%-13.46M
-31.47%-12.82M
-29.51%-13.32M
-53.51%-12.05M
-90.96%-10.94M
-20.89%-9.75M
-95.59%-10.28M
-27.49%-7.85M
-61.97%-5.73M
---8.06M
---5.26M
---6.16M
---3.54M
Income after tax
-35.02%-20.83M
-21.17%-19.36M
-39.31%-18.75M
-26.03%-16.16M
-15.85%-15.43M
-32.66%-15.98M
-23.06%-13.46M
-31.47%-12.82M
-29.51%-13.32M
-53.51%-12.05M
-90.96%-10.94M
-20.89%-9.75M
-95.59%-10.28M
-27.49%-7.85M
-61.97%-5.73M
---8.06M
---5.26M
---6.16M
---3.54M
Net income from continuous operations
-35.02%-20.83M
-21.17%-19.36M
-39.31%-18.75M
-26.03%-16.16M
-15.85%-15.43M
-32.66%-15.98M
-23.06%-13.46M
-31.47%-12.82M
-29.51%-13.32M
-53.51%-12.05M
-90.96%-10.94M
-20.89%-9.75M
-95.59%-10.28M
-27.49%-7.85M
-61.97%-5.73M
---8.06M
---5.26M
---6.16M
---3.54M
Net income attributable to controlling interests
-35.02%-20.83M
-21.17%-19.36M
-39.31%-18.75M
-26.03%-16.16M
-15.85%-15.43M
-32.66%-15.98M
-23.06%-13.46M
-31.47%-12.82M
-29.51%-13.32M
-53.51%-12.05M
-90.96%-10.94M
-20.89%-9.75M
-95.59%-10.28M
-27.49%-7.85M
-61.97%-5.73M
---8.06M
---5.26M
---6.16M
---3.54M
Preferred share dividend
----
----
----
----
----
----
----
----
----
----
----
--0.00
--0.00
----
----
--0.00
--0.00
----
----
Net income attributable to common shareholders
-35.02%-20.83M
-21.17%-19.36M
-39.31%-18.75M
-26.03%-16.16M
-15.85%-15.43M
-32.66%-15.98M
-23.06%-13.46M
-31.47%-12.82M
-29.51%-13.32M
-53.51%-12.05M
-90.96%-10.94M
-20.89%-9.75M
-95.59%-10.28M
-27.49%-7.85M
-61.97%-5.73M
---8.06M
---5.26M
---6.16M
---3.54M
Basic earnings per share
2.66%-0.40
-12.99%-0.50
-30.35%-0.49
-16.36%-0.42
-8.52%-0.41
-28.26%-0.45
4.92%-0.38
-18.34%-0.36
-16.24%-0.38
-40.29%-0.35
-118.51%-0.40
-20.89%-0.31
-95.59%-0.33
-27.49%-0.25
-61.97%-0.18
---0.25
---0.17
---0.19
---0.11
Diluted earnings per share
2.66%-0.40
-12.99%-0.50
-30.35%-0.49
-16.36%-0.42
-8.52%-0.41
-28.26%-0.45
4.92%-0.38
-18.34%-0.36
-16.24%-0.38
-40.29%-0.35
-118.51%-0.40
-20.89%-0.31
-95.59%-0.33
-27.49%-0.25
-61.97%-0.18
---0.25
---0.17
---0.19
---0.11
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--

FAQs

What is the income statement?

The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.
KeyAI